جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.

Research outputs

المخرجات البحثية

مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.

83 مُخرَج نتائج البحث عن «Obesity»

مقالمفتوح (مستودع)20262استشهاد· Semantic Scholar

Adolescent health across Asia Pacific, 2000–23: a systematic analysis for the Global Burden of Disease Study 2023

The Lancet Child & Adolescent Health · مجلد 10 (10) · 731-754

BACKGROUND: The Asia Pacific region is home to more than half of the world's 1·93 billion adolescents (aged 10-24 years). Addressing adolescent health in this region is of global importance, but to date a systematic analysis of key contributors to disease in adolescents has not been done, which is a barrier to responsive action. This systematic analysis of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023 aims to provide a comprehensive assessment of adolescent health across the Asia Pacific region, at both the subregional and national levels, encompassing burden of disease, mortality, and prevalence of adolescent risk factors. METHODS: As part of GBD 2023, we obtained estimates for cause-specific mortality, disability-adjusted life-years (DALYs), and risk factor prevalence by sex for adolescents aged 10-24 years and 5-year age groups (10-14 years, 15-19 years, and 20-24 years) across 44 countries and territories (hereafter referred to collectively as Asia Pacific), grouped by seven UN subregions, from 2000 to 2023. We extracted GBD 2023 population counts and estimates of number and rate (per 100 000 population) for mortality and disease burden (DALYs). Risk prevalence estimates were obtained directly from the Institute for Health Metrics and Evaluation, and binge drinking estimates were sourced from WHO. Estimates are reported with 95% uncertainty intervals (UIs) where possible. UIs were estimated by running 250 draws of the posterior distribution, ordering the draws, and selecting the 2·5th and 97·5th percentiles for each metric. FINDINGS: In 2023, in adolescents across Asia Pacific, there were 637 496 deaths and a total disease burden of 115·8 million DALYs, representing 34·1% of global adolescent deaths and 40·6% of the global adolescent burden of disease. Non-communicable diseases (NCDs; particularly mental disorders) were the leading causes of disease burden and mortality (64·8% of DALYs and 43·9% of deaths). Unintentional and transport injuries were also leading causes of death (14·7% of deaths due to transport injury and 13·3% of deaths due to unintentional injury) and leading causes of disease burden particularly among males in south-eastern Asia. In Melanesia, Micronesia, and some parts of south-eastern Asia (Cambodia, Indonesia, Laos, the Philippines, and Timor-Leste), respiratory infections and tuberculosis remained important contributors. Southern Asia had the largest reduction (1·5% per year) in all-cause DALYs over the study period, and Australia and New Zealand (0·2% per year) had the smallest, with females in Australia and New Zealand showing a slight increase contrary to regional trends. Eastern Asia had the largest reduction (2·8% per year) in all-cause mortality rate and Melanesia (0·8% per year) the smallest. Risk factors generally had between-subregion and within-subregion variation; however, some regional trends stood out, with overweight and obesity increasing in all countries across the region, and binge drinking increasing in more countries than not. In 2023, prevalence of smoking in males exceeded that in females in every country, from 40% difference in Timor-Leste to less than 1% difference in Australia. Anaemia prevalence is decreasing in all countries, but female prevalence was higher and reducing at a slower rate than in males. Bullying prevalence was slightly higher in Polynesia, Micronesia, and Melanesia combined, Australia and New Zealand, and eastern Asia compared with southern and south-eastern Asian subregions. INTERPRETATION: Several patterns were consistent across the region: the dominance of mental disorders and NCDs, the universal rise in overweight and obesity (particularly high in Oceanic countries but increasing rapidly in south and south-eastern Asia), and persistent sex-specific challenges across subregions: unintentional injuries and smoking in males, and anaemia in females. Actions to tackle shared risk factors (while accounting for context-specific local health profiles, workforce deficits, cultural factors, and health system capacity) should not be forgone due to local variation. Future research could focus on subnational variation, intersecting inequalities, and multi-sectoral interventions targeting shared risk factors. Priority actions should include regional investment in adolescent mental health services and obesity prevention, targeted injury reduction strategies for high-risk populations, and sex-specific approaches to smoking cessation and anaemia reduction, delivered through local health systems with the capacity and cultural responsiveness to meet local needs. FUNDING: Gates Foundation and Australian Government.

adolescent healthdisease burdenadolescent mortalitydisability-adjusted life years
مقالمفتوح (مستودع)20261استشهاد· Semantic Scholar

Prevalence of Nutritional Deficiencies in Post-Bariatric Surgery Patients: A Cross-Sectional Analysis.

Journal of Pioneering Medical Science · مجلد 15 (03) · 189-194

Background: Bariatric surgery is an effective treatment for morbid obesity and its associated comorbidities. However, due to altered gastrointestinal anatomy and physiology, patients are at risk of developing nutritional deficiencies, which may impair long-term health and quality of life. Identifying the prevalence of such deficiencies is essential to guide appropriate follow-up and supplementation strategies. Objective: To determine the prevalence of nutritional deficiencies among patients who underwent bariatric surgery and to compare outcomes between sleeve gastrectomy and gastric bypass. Methodology: This cross-sectional analytical study included 365 patients who had undergone bariatric surgery. Adult patients aged 18-65 years with at least six months of postoperative follow-up were enrolled, while those with prior gastrointestinal surgery, chronic systemic illnesses or incomplete records were excluded. Data were collected on demographics, surgical procedure type and laboratory investigations including hemoglobin, ferritin, vitamin B12, folate, calcium and vitamin D. Standardized cut-off values were used to define deficiencies. Statistical analysis was performed using SPSS version 26, with results expressed as Mean±Standard deviation for continuous variables and frequencies and percentages for categorical variables. Comparisons between groups were made using Chi-square test, with p<0.05 considered significant. Results: Of 365 patients, 208 (57.0%) underwent sleeve gastrectomy and 157 (43.0%) gastric bypass. The mean age was 40.9±10.1 years and 220 (60.3%) were female. The most common deficiency was vitamin D, present in 202 patients (55.3%), followed by iron deficiency in 146 (40.0%) and anemia in 142 (38.9%). Vitamin B12 deficiency was observed in 110 (30.1%), folate in 81 (22.2%) and calcium in 76 (20.8%). Multiple deficiencies were noted in 134 patients (36.7%). Deficiencies were significantly more frequent in gastric bypass compared to sleeve gastrectomy for vitamin D (62.4% vs. 50.0%, p = 0.02) and iron (45.9% vs. 35.6%, p = 0.03). Women were more likely to have anemia (45.9% vs. 28.3%, p = 0.001) and vitamin D deficiency (60.5 vs. 47.6%, p = 0.01). The prevalence of deficiencies increased with time since surgery, with the highest rates observed beyond two years. Conclusion: Nutritional deficiencies are common after bariatric surgery, particularly vitamin D and iron deficiency and are more prevalent following gastric bypass than sleeve gastrectomy. Women and patients with longer follow-up durations are at greater risk. These findings underscore the need for structured postoperative monitoring, lifelong supplementation and patient education to prevent long-term health complications.

bariatric surgerynutritional deficiencyvitamin D deficiencyiron deficiency
مقالوصول مفتوح20261استشهاد· Semantic Scholar

Knowledge, attitudes, and practices toward obesity and their determinants: a cross-sectional study

Frontiers in Public Health · مجلد 14 · 1768449-1768449

Background: Obesity remains a major global health challenge and a significant contributor to chronic diseases. This study aimed to assess knowledge, attitudes, and practices (KAP) related to obesity and to identify sociodemographic and clinical factors influencing these domains among individuals with obesity. Methods: A cross-sectional survey was conducted using a convenience, non-probability sampling method among individuals with obesity recruited from hospitals, health clinics, and community settings. Obesity-related knowledge, attitudes, and practices were assessed, and multinomial regression analyses were performed to identify factors associated with KAP outcomes. Results: A total of 419 participants were included, with a nearly equal gender distribution and a predominantly young adult population, most of whom had university-level education. Overall, 45.3% demonstrated satisfactory knowledge, 42.2% exhibited positive attitudes, and 43.0% reported effective practices regarding obesity management. Increasing age (OR = 1.361, 95% CI: 1.134-1.635) and higher education (OR = 2.417, 95% CI: 1.575-3.710) were significantly associated with satisfactory knowledge. Male participants were more likely to exhibit negative attitudes than females (OR = 1.909, 95% CI: 1.141-3.195), while individuals diagnosed with obesity were less likely to report non-satisfactory attitudes (OR = 0.495, 95% CI: 0.290-0.845). Effective practices were associated with age (OR = 1.296, 95% CI: 1.076-1.562) and obesity diagnosis (OR = 0.475, 95% CI: 0.278-0.811). Perceptions of nutritional value significantly influenced both knowledge (OR = 0.741, 95% CI: 0.571-0.961) and practices (OR = 0.384, 95% CI: 0.288-0.512). Conclusion: The findings highlight the role of key sociodemographic and clinical factors-particularly age, education, and obesity diagnosis-in shaping obesity-related knowledge, attitudes, and practices. Targeted educational and behavioral interventions, especially among younger individuals and males, along with improved awareness of nutritional value, may enhance obesity management outcomes.

obesityknowledge, attitudes and practicesobesity treatmentsociodemographic factors
مقالوصول مفتوح2026

Knowledge, Attitudes, and Use of Antidiabetic Medications for Weight Loss Among Adults in Riyadh, Saudi Arabia: A Cross-Sectional Study

Cureus

BackgroundThe increasing use of anti-diabetic drugs, particularly glucagon-like peptide-1 receptor agonists (GLP-1 RAs), for weight loss has prompted concerns about public awareness, attitudes, and usage.In Saudi Arabia, a substantial proportion of adults have obesity or are overweight, highlighting the considerable burden of obesity.Meanwhile, the increasing use of GLP-1 RAs for weight management underscores the importance of assessing public knowledge and attitudes toward these medications. ObjectiveThe objective of this study is to assess knowledge, attitudes, and practices regarding antidiabetic medications used for weight loss among adult residents of Riyadh, Saudi Arabia. MethodsThe cross-sectional survey included 282 adult residents of Riyadh.A self-administered electronic questionnaire was sent using a non-probability convenience sampling method.The questionnaire evaluated sociodemographic variables, knowledge, attitudes, and practices about antidiabetic medicines used for weight loss.Data were analyzed using nonparametric tests, Spearman's ρ correlation, and multivariable linear and binary logistic regression analyses. ResultsOf the 282 participants, 70.9% were female and 68.4% were married.The median knowledge score was 15.0 (interquartile range (IQR), 12.0-18.0),and the median attitude score was 23.0 (IQR, 21.0-25.0).Knowledge and attitude scores showed a weak positive correlation (Spearman's ρ = 0.254, p < 0.001).Overall, 76 participants (27.0%) reported using antidiabetic medications for weight reduction, with Ozempic (55.3%) and Mounjaro (44.7%) being the most commonly used medications.Female gender was independently associated with higher knowledge scores, whereas non-medical occupation was associated with lower knowledge and attitude scores.Participants with chronic disease had higher odds of weight-loss medication use, whereas higher attitude scores were associated with lower odds of use. ConclusionAdults in Riyadh demonstrated important knowledge gaps regarding weight-loss medications.Knowledge and attitudes varied by occupation, while medication use was independently associated with chronic disease status and attitude scores, highlighting the need for evidence-based education and medically supervised use.

antidiabetic drugsweight lossGLP-1 receptor agonistsobesity
مراجعةمفتوح (مستودع)2026

Preoperative risk factors for adverse outcomes following total knee arthroplasty: a systematic review and meta-analysis

Annals of Middle Eastern Medicine · مجلد 2 (3) · 302-311

This systematic review and meta-analysis evaluated preoperative patient factors associated with adverse outcomes after primary total knee arthroplasty (TKA). PubMed and Crossref were searched from 2010 to 2025 according to PRISMA guidance, and the protocol was registered in PROSPERO (CRD420261297849). Eligible studies included adults undergoing primary TKA and reported diabetes mellitus, hypertension, obesity, morbid obesity, or sex in relation to readmission, revision surgery, or deep infection. Random-effects generic inverse variance meta-analyses were performed using odds ratios from adjusted models when available; unadjusted or calculated estimates were used only when adjusted estimates were unavailable. Twelve cohort studies including 1,586,680 patients were included. Diabetes mellitus was associated with higher odds of readmission (OR 1.17, 95% CI 1.05-1.30) and revision surgery (OR 1.17, 95% CI 1.03-1.32). Morbid obesity (BMI ≥40 kg/m²) was associated with readmission, revision surgery, and deep infection. Male sex was associated with readmission and revision surgery, while non-morbid obesity and hypertension were not consistently associated with adverse outcomes. These findings support preoperative risk stratification and optimization for diabetes and morbid obesity before elective TKA. Interpretation should remain cautious because included studies were observational and heterogeneity was substantial in several analyses.

total knee arthroplastypreoperative risk factorsadverse outcomesdiabetes mellitus
مراجعةوصول مفتوح2026

Hepatoprotective effects of empagliflozin in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of preclinical studies

Frontiers in Pharmacology · مجلد 17 · 1822157-1822157

Background: The worldwide burden of metabolic dysfunction-associated steatotic liver disease (MASLD) is rising sharply, powered by high prevalence of obesity and its associated metabolic insults. Though urgent, definitive treatment is not yet available. Empagliflozin, a sodium glucose co-transporter inhibitor has been suggested in both human and animal studies to have diverse beneficial effects in MASLD by anti-inflammation and anti-oxidative stress effects, but many of the underlying mechanisms remain unexplained. The main aim of this systematic review and meta-analysis was to evaluate the effects of empagliflozin's in preclinical animal studies trying to view new horizons for future treatment of MASLD. Methods: we searched the related animal preclinical studies in databases including Scopus, Web of Science, Cochrane library, Wily online library and PubMed. The research team screened the literature and extracted data; any discrepancies were resolved by the research team leader through discussion. The quality of research methods was assessed by SYRCLE (systematic review center for laboratory animal experimentation) risk of bias tool. The meta-analysis was guided by the Cochrane Handbook; statistical analyses were conducted via RevMan 5.4 offline version and Comprehensive Met analysis V3 software. Results: Our meta-analysis included 17 studies, involving 584 animals. In comparison with the model group, empagliflozin significantly reduced steatosis markers including hepatic burden of lipids, including triglycerides and cholesterol, NAFLD Activity Score (NAS) and total serum cholesterol (TC). It also significantly reduced hepatic fibrosis markers including fibrosis grade, transforming growth factor-β (TGF-β) and collagen type I alpha 1 chain) COL1A1). Beyond its anti-steatofibrotic effects, empagliflozin significantly downregulated hepatic expression of inflammatory and oxidative markers including tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6) and malondialdehyde (MDA). Moreover, empagliflozin significantly improved glycemic indices including Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), serum insulin, and fasting blood sugar (FBS). Conclusion: Empagliflozin significantly protected the liver against steatosis and fibrosis by mitigating hepatic inflammation, oxidative stress and insulin resistance.

empagliflozinnon-alcoholic fatty liver diseaseSGLT2 inhibitorshepatic steatosis
مقالوصول مغلق2026

A Critical Review of the Biological Significance and Synthesis Challenges of Phytonutrients

Current Pharmaceutical Design · مجلد 32

These nutraceuticals are bioactive molecules derived from foods that are valuable for human and animal health. They are easy to find, inexpensive, and have fewer side effects than allopathic medicine, and are thus used to treat many diseases. Modern lifestyles, characterized by the high consumption of processed foods, alcohol use, and sedentary behavior, are primary drivers of chronic conditions, including diabetes, obesity, cancer, and neurodegenerative diseases. Even present modern medical therapies have not been able to get rid of side effects and mortality due to therapy. Plant-rich diets, especially fruits and vegetables, are an important part of the development of these compounds, mostly as enhancers of immunity and overall well-being. Nutrition supplements are perceived as having a healthy profile, with safe, easy, and routine incorporation into everyday diets, driven by their growing popularity, rising public awareness, and scientific validation. Nonetheless, the extraction of bioactive compounds from natural sources has faced challenges such as low yields, seasonality, geographic dependence, and the extensive time required for cultivation. In addition, traditional extraction and purification methods for such compounds are slow, resource-intensive, and extremely damaging to the environment through the overuse of solvents and overharvesting of plants, endangering biodiversity. Emerging methods that leverage synthetic and semi-synthetic techniques are increasingly seeking to address challenges in the extraction of bioactive compounds for the large-scale production of high-quality, highly bioactive molecules. This review discusses nutraceutical compounds from various perspectives, including their biological significance and the challenges of extraction and synthesis. Nevertheless, limitations exist, including expensive production costs, complexity of synthesis, and difficulties in replicating natural structures and their activities.

phytochemicalsnutraceuticalsbioactive compoundsnatural product isolation
مراجعةوصول مفتوح2026

Prophylactic mesh placement in midline laparotomy for patients with obesity: A systematic review and meta-analysis of evidence on safety, efficacy, and clinical guidelines

AIMS Medical Science · مجلد 13 (1) · 89-110

BackgroundA midline laparotomy causes an incisional hernia that is still prevalent and aggravated by obesity and comorbid conditions. Prophylactic mesh reinforcement (PMR) has also been suggested as a way to transform a high-tension suture line into a load-sharing repair, although concerns have been raised about patient selection, plane, and safety.MethodsOur preferred Reporting items for systemic review and meta-analysis (PRISMA)-compliant systematic review took randomized trials that compared PMR and primary suture in an elective midline laparotomy and was supplemented by modern meta-analyses, a network meta-analysis of mesh planes, and its safety data over long term. The main outcome was an incisional hernia (IH) at 12 months; secondary outcomes were surgical-site infection (SSI), seroma, chronic pain, reoperation, and quality of life. Grading of recommendations assessment, development and evaluation (GRADE) was used to assess the certainty.ResultsAcross randomized evidence, PMR reduced the IH with a pooled risk ratio near 0.38 (95% CI ~ 0.24–0.58) over 12–67 months. Long-term extensions confirmed the durability to five years. For obesity-restricted datasets, the effects trended towards being beneficial, but did not reach statistical significance (OR 0.59, 95% CI 0.34–1.01; p = 0.06), thus reflecting imprecision and heterogeneity. SSI did not increase with PMR in clean fields, whereas seroma was more frequent, especially with onlay placement without a consistent rise in chronic pain. Reoperation and explantation were uncommon and numerically lower after retromuscular placement than after onlay among reoperated patients. The network meta-analysis ranked onlay and retromuscular as the highest for IH prevention; taken with safety profiles, retromuscular emerged as a preferred option in experienced centers when the anatomy permits. The overall certainty for IH prevention was moderate; for obesity-restricted estimates, the overall certainty is low due to imprecision.ConclusionsIn patients with obesity, the current evidence suggests a possible benefit of PMR, but estimates remain imprecise and not statistically definitive, thus highlighting the need for targeted, adequately powered trials.

midline laparotomyincisional herniaobesityretromuscular mesh
مراجعةمفتوح (مستودع)2026

The Impact of Body Weight on Aspirin’s Antiplatelet Efficacy: A Narrative Review of Conflicting Evidences and Clinical Implications

Advanced Health Science and Technology Journal · مجلد 2 (1) · 21-26

Abstract Aspirin is one of the oldest and most used anti-platelet medications for the prevention of cardiovascular diseases. There has been conflicting research recently about how body weight affects the antiplatelet effectiveness of aspirin. The purpose of this narrative review was to examine the recent research on the connection between aspirin responsiveness, platelet function, and obesity. To find patterns and discrepancies, pertinent research from PubMed, Scopus, and Google Scholar was rigorously examined and compiled. While some studies showed no discernible effect, others highlighted methodological and population-specific variations by reporting decreased aspirin efficacy in people with higher body weight because of increased platelet reactivity, aspirin deactivation, and altered pharmacokinetics, underscoring the need for well-designed, large-scale clinical investigations. The need for carefully planned, extensive clinical studies is highlighted by the fact that the evidence is still equivocal overall. A better understanding of these mechanisms may support the development of personalized antiplatelet strategies, including tailored aspirin dosing in selected subgroups such as obese patients with high thrombotic risk.

aspirinbody weightobesityantiplatelet efficacy
مراجعةوصول مفتوح2026

Developmental transition in pathophysiological mechanisms of pediatric idiopathic intracranial hypertension and growth plate disorders: A multi-level structural equational modeling systematic review and meta-analysis

Brain and Spine · مجلد 6 · 106164-106164

Introduction: Pediatric idiopathic intracranial hypertension (IIH) and growth plate disorders (GPD) show parallel epidemiological trends and carry possible pathophysiological links, especially regarding obesity and hormonal dysregulation. This study investigated their indirect relationship through structural equation modeling (SEM) to identify age-dependent mechanisms and guide precision treatment strategies. Methods: Following PRISMA 2020 guidelines, we searched literature databases from inception to May 15, 2025, identifying studies reporting pediatric IIH and/or GPD parameters. SEM analysis was performed with age-stratified models to evaluate the mediating effects of obesity and hormonal factors between prepubertal (<10-12 years) and postpubertal (>10-12 years) cohorts. Results: We included 22 eligible studies with total of 2293 individuals. SEM revealed peculiar age-dependent mechanisms. In prepubertal children, venous pressure (β = 0.68, P-value<0.001) and vitamin D/hormonal pathways (β = 0.56, P-value<0.001) dominated, with obesity showing minimal effect (β = 0.28, P-value = 0.001). In a controverse manner, in postpubertal patients, the obesity pathway predominated (β = 0.76, P-value<0.001) with reduced venous (β = 0.29, P-value = 0.003) and hormonal (β = 0.16, P-value = 0.038) contributions. Mechanism-specific therapeutic efficacy showed parallel patterns: acetazolamide/surgical interventions were superior for venous-dominant cases (g = 1.86/1.74), while weight management demonstrated greatest efficacy for obesity-dominant phenotypes (g = 1.75). Vitamin D supplementation showed significant benefit only in hormonal-dominant cases (g = 1.64). Conclusions: Pediatric IIH demonstrates fundamental mechanistic heterogeneity across development. A puberty-associated shift from venous/hormonal to obesity-dominant mechanisms explains the changing demographics and provides a framework for precision treatment. Targeted therapeutic approaches based on dominant mechanisms showed 63% improved outcomes compared to standard of care of IIH.

pediatric idiopathic intracranial hypertensiongrowth plate disordersobesitypuberty
مراجعةمفتوح (مستودع)202542استشهاد· Semantic Scholar

Antioxidative and Anticancer Potential of Luteolin: A Comprehensive Approach Against Wide Range of Human Malignancies

Food Science & Nutrition · مجلد 13 (1) · e4682-e4682

Luteolin is widely distributed phytochemical, a flavonoid, in kingdom plantae. Luteolin with potential antioxidant activity prevent ROS-induced damages and reduce oxidative stress which is mainly responsible in pathogenesis of many diseases. Several chemo preventive activities and therapeutic benefits are associated with luteolin. Luteolin prevents cancer via modulation of numerous pathways, that is, by inactivating proteins; such as procaspase-9, CDC2 and cyclin B or upregulation of caspase-9 and caspase-3, cytochrome C, cyclin A, CDK2, and APAF-1, in turn inducing cell cycle arrest as well as apoptosis. It also enhances phosphorylation of p53 and expression level of p53-targeted downstream gene. By Increasing BAX protein expression; decreasing VEGF and Bcl-2 expression it can initiate cell cycle arrest and apoptosis. Luteolin can stimulate mitochondrial-modulated functions to cause cellular death. It can also reduce expression levels of p-Akt, p-EGFR, p-Erk1/2, and p-STAT3. Luteolin plays positive role against cardiovascular disorders by improving cardiac function, decreasing the release of inflammatory cytokines and cardiac enzymes, prevention of cardiac fibrosis and hypertrophy; enhances level of CTGF, TGFβ1, ANP, Nox2, Nox4 gene expressions. Meanwhile suppresses TGFβ1 expression and phosphorylation of JNK. Luteolin helps fight diabetes via inhibition of alpha-glucosidase and ChE activity. It can reduce activity levels of catalase, superoxide dismutase, and GS4. It can improve blood glucose, insulin, HOMA-IR, and HbA1c levels. This review is an attempt to elaborate molecular targets of luteolin and its role in modulating irregularities in cellular pathways to overcome severe outcomes during diseases including cancer, cardiovascular disorders, diabetes, obesity, inflammation, Alzheimer's disease, Parkinson's disease, hepatic disorders, renal disorders, brain injury, and asthma. As luteolin has enormous therapeutic benefits, it could be a potential candidate in future drug development strategies.

luteolinflavonoidsantioxidant activityanticancer activity
مراجعةوصول مفتوح202519استشهاد· Semantic Scholar

Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use: A Systematic Review

Cureus · مجلد 17 (9) · e92454-e92454

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have recently gained widespread use among patients with type 2 diabetes mellitus or obesity, owing to their substantial impact in lowering blood glucose levels and reducing body weight. Apart from this, the FDA Adverse Event Reporting System (FAERS) identified several dermatological side effects, including hair loss, associated with the administration of GLP-1 RAs, prompting further research. This systematic review aimed to provide a comprehensive and up-to-date overview of hair loss related to the use of GLP-1 RAs. The search strategy utilized PubMed, SCOPUS, and Web of Science databases using key terms: (("GLP-1 receptor agonist"[Mesh] OR "GLP1- receptor agonist"[tiab] OR "Glucagon-Like Peptide 1"[tiab] OR "GLP-1 agonist"[tiab] OR semaglutide[tiab] OR liraglutide[tiab] OR tirzepatide[tiab] OR exenatide[tiab] OR dulaglutide[tiab]) AND (hair loss[Mesh] OR alopecia[tiab] OR "telogen effluvium"[tiab] OR "alopecia areata"[tiab] OR hair[tiab]) ). Including all primary English studies, the hair loss outcomes associated with the use of GLP-1 RA in adults were reported without time restriction. A total of five relevant studies were included in this review, encompassing 2,905 adult patients who received subcutaneous trizepatide mainly on a weekly basis. The study yielded conflicting findings, with some indicating significant improvement and hair regrowth, while others reported hair loss as an adverse dermatological event. Further research is recommended to clarify the relationship between GLP-1 RAs and alopecia.

GLP-1 receptor agonistshair losstelogen effluviumalopecia areata
مقالوصول مفتوح20259استشهاد· Semantic Scholar

Prevalence and impact of sociodemographic factors, comorbidities, and lifestyle on diabetes complications among patients with type 2 diabetes in Riyadh

Scientific Reports · مجلد 15 (1) · 17299-17299

Diabetes mellitus (DM) is a growing public health concern globally, particularly in Saudi Arabia, where increasing prevalence is associated with significant morbidity. This study aimed to assess the prevalence of diabetes-related complications among patients in Riyadh and examine the impact of sociodemographic factors, comorbidities, and lifestyle habits on these complications. A cross-sectional study was conducted with 980 diabetic patients attending health centers in Riyadh from March to April 2023. Data were collected via a validated bilingual questionnaire that captured sociodemographic information, diabetes-related variables, comorbid conditions, lifestyle habits, and complications. Statistical analyses, including descriptive statistics, chi-square tests, and binary regression, were performed via SPSS to identify significant associations. A p-value less than 0.05 was considered significant for all comparisons. Among the participants (980), 38% (378) reported diabetes-related complications, primarily neuropathy (30%), retinopathy (25%), and cardiovascular diseases (20%). Complications were significantly associated with older age (p < 0.001) and longer diabetes duration (more than 5 years; p < 0.001). Individuals with hypertension, hyperlipidemia, heart disease, kidney disease, and obesity had significantly higher complication rates than those without these conditions (p < 0.05). The most pronounced association was observed in participants with heart disease (85% vs. 15%; RR = 1.506), highlighting the need for better management of these comorbidities. Consuming fruits and vegetables, milk, and regular exercise were inversely associated with the risk of complications (p < 0.05). Conversely, sugary drinks, white bread, sheesha/vaping, and inadequate sleep were linked to increased risk (p < 0.05), highlighting the protective role of healthy dietary and lifestyle habits. This study highlights the impact of sociodemographic factors and lifestyle choices-such as age, education, family history, comorbidities, and poor diet-on diabetes complications. While early detection and lifestyle interventions are vital, a cautious approach is needed when applying these findings to other regions, given differences in socioeconomic circumstances.

type 2 diabetesdiabetes complicationsdiabetic neuropathydiabetic retinopathy